Using Data-Driven Rules to Predict Mortality in Severe Community Acquired Pneumonia
暂无分享,去创建一个
Gilles Clermont | Chuang Wu | Roni Rosenfeld | R. Rosenfeld | G. Clermont | Chuang Wu | Roni Rosenfeld
[1] R. Samudrala,et al. Simple Linear Model Provides Highly Accurate Genotypic Predictions of HIV-1 Drug Resistance , 2003, Antiviral therapy.
[2] K. Reinhart,et al. Comparison of the performance of SAPS II, SAPS 3, APACHE II, and their customized prognostic models in a surgical intensive care unit. , 2008, British journal of anaesthesia.
[3] J. Vincent,et al. Classification, incidence, and outcomes of sepsis and multiple organ failure. , 2007, Contributions to nephrology.
[4] M. Leinonen,et al. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. , 1990, The European respiratory journal.
[5] M. Feldmann,et al. The rationale for the current boom in anti-TNFα treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFα and minimise hazards? , 1999, Annals of the rheumatic diseases.
[6] Steven B. Johnson,et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels* , 2004, Critical care medicine.
[7] Evangelos Triantaphyllou,et al. On the minimum number of logical clauses inferred from examples , 1996, Comput. Oper. Res..
[8] M. Fine,et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.
[9] M. Fine,et al. Prognosis of patients hospitalized with community-acquired pneumonia. , 1990, The American journal of medicine.
[10] G. Clermont,et al. In silico design of clinical trials: A method coming of age , 2004, Critical care medicine.
[11] R. Shafer,et al. Genotypic predictors of human immunodeficiency virus type 1 drug resistance , 2006, Proceedings of the National Academy of Sciences.
[12] R. Read. Experimental therapies for sepsis directed against tumour necrosis factor. , 1998, The Journal of antimicrobial chemotherapy.
[13] Bekele Afessa,et al. Comparison of APACHE III, APACHE IV, SAPS 3, and MPM0III and influence of resuscitation status on model performance. , 2012, Chest.
[14] Peter Clark,et al. Rule Induction with CN2: Some Recent Improvements , 1991, EWSL.
[15] M. Trabucchi,et al. Is pneumonia still the old man's friend? , 2003, Archives of internal medicine.
[16] Jianhua Chen,et al. An incremental learning algorithm for constructing Boolean functions from positive and negative examples , 2002, Comput. Oper. Res..
[17] D C Angus,et al. Severity scoring systems in the modern intensive care unit. , 1998, Annals of the Academy of Medicine, Singapore.
[18] Brendan Larder,et al. Non‐parametric methods to predict HIV drug susceptibility phenotype from genotype , 2003, Statistics in medicine.
[19] John A Kellum,et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. , 2007, Archives of internal medicine.
[20] Sorin Draghici,et al. Predicting HIV drug resistance with neural networks , 2003, Bioinform..
[21] J. Zimmerman,et al. Acute Physiology and Chronic Health Evaluation (APACHE) IV: Hospital mortality assessment for today’s critically ill patients* , 2006, Critical care medicine.
[22] E. Ibrahim,et al. Community acquired acute bacterial and atypical pneumonia in Saudi Arabia. , 1992, Thorax.
[23] Margaret M Parker,et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.
[24] C Kooperberg,et al. Sequence Analysis Using Logic Regression , 2001, Genetic epidemiology.
[25] James F. Gimpel. A Method of Producing a Boolean Function Having an Arbitrarily Prescribed Prime Implicant Table , 1965, IEEE Trans. Electron. Comput..
[26] D Draper,et al. Changes in sickness at admission following the introduction of the prospective payment system. , 1990, JAMA.
[27] G. Clermont,et al. Predicting hospital mortality for patients in the intensive care unit: A comparison of artificial neural networks with logistic regression models , 2001, Critical care medicine.
[28] S. Calvano,et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. , 2002, The Journal of infectious diseases.
[29] M. Fine,et al. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. , 1990, The American journal of medicine.
[30] Sue E. Poynter,et al. Role of gene polymorphisms in sepsis. , 2002, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[31] J. Schapiro,et al. Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333. , 2000, The Journal of infectious diseases.
[32] M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.
[33] J Ean,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.
[34] G. Clermont,et al. Comparison of Cox and Gray’s survival models in severe sepsis* , 2004, Critical care medicine.
[35] Thomas Lengauer,et al. Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] Ingo Ruczinski,et al. Identifying interacting SNPs using Monte Carlo logic regression , 2005, Genetic epidemiology.
[37] Eduard E Vasilevskis,et al. Mortality probability model III and simplified acute physiology score II: assessing their value in predicting length of stay and comparison to APACHE IV. , 2009, Chest.
[38] T. Marrie,et al. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.
[39] R. Cantor,et al. Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia. , 2002, Chest.
[40] B. Larder,et al. Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks. , 2003, The Journal of infectious diseases.
[41] F. Stüber. Effects of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy? , 2001, Journal of the American Society of Nephrology : JASN.
[43] B. Grandbastien,et al. Can generic scores (Pediatric Risk of Mortality and Pediatric Index of Mortality) replace specific scores in predicting the outcome of presumed meningococcal septic shock in children? , 2001, Critical care medicine.
[44] Mauricio G. C. Resende,et al. A continuous approach to inductive inference , 1992, Math. Program..
[45] A. Muriel,et al. Performance of the third-generation models of severity scoring systems (APACHE IV, SAPS 3 and MPM-III) in acute kidney injury critically ill patients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[46] Luc De Raedt,et al. Phase Transitions and Stochastic Local Search in k-Term DNF Learning , 2002, ECML.
[47] J. Ross Quinlan,et al. Induction of Decision Trees , 1986, Machine Learning.
[48] Gary Garber,et al. The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000) , 2001 .
[49] Mitchell M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.
[50] George E. Hale. The Law of Sun-Spot Polarity. , 1924 .
[51] D Draper,et al. Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. , 1988, JAMA.
[52] Thomas Lengauer,et al. Geno2pheno: Interpreting Genotypic HIV Drug Resistance Tests , 2001, IEEE Intell. Syst..
[53] J. Helterbrand,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .
[54] D. Hosmer,et al. A review of goodness of fit statistics for use in the development of logistic regression models. , 1982, American journal of epidemiology.
[55] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[56] G. Bernard,et al. The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis * , 2004, Critical care medicine.
[57] M. Fine,et al. Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia , 1995, Journal of General Internal Medicine.